A lift door failing to open ahead of a concert illustrates the issues with accessibility that columnist Betty Vertin's sons face regularly.

DMD patients who switched to the experimental therapy deramiocel in a trial showed slower declines in upper limb function ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Last week, I lost my dear friend Aloysius Teo, who passed away at ...

Because technology is a part of columnist Shalom Lim's daily life with Duchenne muscular dystrophy, he weighs in on the ...

The FDA has given the go-ahead for a trial testing an oral therapy that aims to aid muscle regeneration in adults with FSHD, ...

The realization that they were not alone set the tone for MDA Engage: Chicago, a free symposium held Sept. 26 in suburban ...

New treatments for muscular dystrophy are moving forward, but some promising therapies have fallen short in trials, two ...

In the past six months, FSHD has destroyed the muscles in columnist Robin Stemple's arms and hands, and now he fears he can't play piano.

People living with neuromuscular diseases and their families should help shape new treatments from the very start, rather than weighing in only after key decisions are made, according to experts and ...

Kelsey Saxon shares how she went from surviving to healing after her son received gene therapy for Duchenne muscular ...